Stateside's Canadian Microcap Board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ayeyou who wrote (1711)	11/14/2016 7:34:28 AM
From: ogi	Read Replies (1) of 1728

Rather strange that in April they were expecting to initiate trials in that quarter and were already manufacturing new batches of the vaccine then. One thing for certain every biotech I have cannot Fathom an expected time line! 2016-04-05 11:09 AT - News Release stockwatch.com "Manufacturing of the vaccine is nearing completion at the facilities of BriaCell's partner, University of California Davis. As prior noted, UC Davis is manufacturing compliant cGMP-grade (current good manufacturing practice) BriaVax which will be used in dosing patients during the coming trial. The company has already been notified that several BriaVax batches have been completed and hopes to report further on this matter in the coming weeks. "

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next